Robert Treat Chatterton

Prof. Robert Treat Chatterton

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
RCRobert Treat Chatterton
Robert Treat Chatterton
EMEsnar T Mateo
Esnar T Mateo
NHNanjiang Hou
Nanjiang Hou
ARAlfred W Rademaker
Alfred W Rademaker
SASimbi Acharya
Simbi Acharya
MMMonica Morrow
Monica Morrow
The objective of the study was to characterize salivary sex steroid levels in 56 women undergoing annual mammography who were participating in a breast density study at the Lynn Sage Breast Center of Northwestern Memorial Hospital, and to determine the predictability of the patterns within women. Saliva was collected daily by the women at home for one complete menstrual cycle and then again at approximately 6-month intervals. The occurrence of sporadic anovulatory cycles was identified in 12 subjects, and persistent oestradiol (OE2) elevation in all three cycles without significant progesterone levels occurred in another five subjects. In addition, both OE2 and progesterone were significantly lower in initial menstrual cycles than in subsequent cycles, suggestive of an effect of participation in the study on hormone levels. Initial salivary OE2 levels were not good predictors of corresponding levels in either follicular or luteal phases of the menstrual cycles at the 6-month intervals. However, after the initial cycle, progesterone levels were highly predictable within individuals over a period of 6 months (r=0.78, P< 0.001). The study emphasizes the natural variation among and within women in the absence of any intervention, and indicates the need for properly controlled studies before attributing changes in hormonal levels to therapy. In addition, it emphasizes the importance of sampling at multiple time points when examining the relationship between hormones and risk.

1 June 2004 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
RCRobert Treat Chatterton
Robert Treat Chatterton
AGAngela S. Geiger
Angela S. Geiger
Seema Ahsan KhanSeema Ahsan Khan
Seema Ahsan Khan
IHIrene B. Helenowski
Irene B. Helenowski
BJBorko D. Jovanovic
Borko D. Jovanovic
PGPeter Gann
Peter Gann
The purpose of the study was to measure the concentrations of estradiol, its primary precursors, and factors with which it interacts in the breast, and determine their sources of variation. Nipple aspirate fluid (NAF) was collected from premenopausal women during the mid-luteal phase of the menstrual cycle. The fluid was diluted and unconjugated steroids were extracted. Estradiol was further purified by a solvent partition into aqueous NaOH. Androgens were measured in the non-phenolic fraction. Water-soluble, conjugated steroids and proteins were measured in the aqueous residue. All analytes were measured by immunoassays. Permutation methods were used to determine the correlations over multiple periods of time. The average concentration of estradiol in NAF was 435 pmol/L after purification but was many times higher when assayed without purification. Estrone and dehydroepiandrosterone (DHEA) sulfates were present in 3.7 and 75 μmol/L concentrations, respectively, while unconjugated androstenedione and DHEA were present in nanomole per liter concentrations. Lack of the steroid sulfates in NAF in 19% of subjects had no effect on NAF estradiol levels but was associated with a 77% lower concentration of unconjugated DHEA. Progesterone was present in concentrations that were 3- to 4-fold higher than normal serum concentrations (mean: 291 nmol/L). Cathepsin D, epidermal growth factor, and interleukin 6 had average values of 3.4 μg/mL, 424 ng/mL, and 1.7 ng/mL, respectively. Correlations between breasts were between 0.57 and 0.84 for the several analytes; correlations over time ranged from 0.64 and 0.93 with estrone sulfate highest in both categories. The lower correlation between breasts than within breasts indicates that local factors play an important role in determining the levels of many of these analytes in the breast. The high stability of the concentrations of several analytes over time indicates that fluctuations in environmental factors have little immediate effect on levels in the breast, and portends their utility as surrogate breast cancer risk markers.

10 July 2014 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
HHHong Hu
Hong Hu
JWJun Wang
Jun Wang
AGAkash Gupta
Akash Gupta
ASAli Shidfar
Ali Shidfar
DBDaniel Branstetter
Daniel Branstetter
Seema Ahsan KhanSeema Ahsan Khan
Seema Ahsan Khan

29 August 2012 in Environmental Health
Verified
Journal Article
Open access
PDF file
VPVictoria Persky
Victoria Persky
JPJulie Piorkowski
Julie Piorkowski
MTMary Turyk
Mary Turyk
SFSally A Freels
Sally A Freels
RCRobert Treat Chatterton
Robert Treat Chatterton
KMKenneth McCann
Kenneth McCann
Studies have shown associations of diabetes and endogenous hormones with exposure to a wide variety of organochlorines. We have previously reported positive associations of polychlorinated biphenyls (PCBs) and inverse associations of selected steroid hormones with diabetes in postmenopausal women previously employed in a capacitor manufacturing plant.

1 March 2005 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
RCRobert Treat Chatterton
Robert Treat Chatterton
AGAngela S. Geiger
Angela S. Geiger
EMEsnar T. Mateo
Esnar T. Mateo
IHIrene B. Helenowski
Irene B. Helenowski
PGPeter H. Gann
Peter H. Gann
The effects of ovarian suppression by oral contraceptives as well as hormone replacement therapy were studied on hormone levels and on products of hormone action in nipple aspirate fluid (NAF) from breasts of pre- and postmenopausal women. Multiple samples per subject revealed high consistency (intraclass correlation coefficients) for all products measured. Compared with premenopausal women, NAF progesterone was much lower in postmenopausal women, but NAF androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfate concentrations were not different. With oral contraceptive use, estradiol, estrone sulfate, and progesterone levels were similarly lower in serum and NAF. In postmenopausal women, NAF estradiol and estrone sulfate were not significantly less than those in premenopausal women, nor were epidermal growth factor or cathepsin D levels, but IL-6 was elevated. Despite corresponding changes in hormones in serum and NAF over time, correlations based on simultaneous sampling were not significant. It is concluded that: 1) potential precursors of estradiol remain at comparable levels in the breast after menopause; 2) local synthesis is important for maintenance of estradiol levels in NAF of postmenopausal women but less important for progesterone; and 3) changes in the serum parameters are accurately reflected in NAF, but only after a matter of days. These findings provide additional validation for the physiological relevance of NAF hormone levels as potential breast cancer risk markers.

27 August 2003 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
RCRobert Treat Chatterton
Robert Treat Chatterton
AGAngela S. Geiger
Angela S. Geiger
PGPeter H. Gann
Peter H. Gann
SKSeema A. Khan
Seema A. Khan